Prostatic Hypertrophy, Benign Completed Phase Trials for Dutasteride (DB01126)

Also known as: Benign Prostatic Hypertrophy (BPH) / Benign Prostatic Hypertrophy / BPH / Prostatic hypertrophy (benign) / Benign prostatic hyperplasia / Enlarged prostate (benign)

IndicationStatusPhase
DBCOND0029457 (Prostatic Hypertrophy, Benign)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00382356Dutasteride After Failure of Finasteride In the Management of Symptomatic Prostatic Enlargement/Hypertrophy (BPE/H)Treatment